Haematological Disorders Uterine Leiomyoma
Conditions
Interventions
tourniquet alone
Tourniquet plus tablet misoprostol
Sponsors
College of Medicine University of Nigeria ItukuOzalla Campus and African Research League
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: All consenting women of reproductive age diagnosed of symptomatic uterine fibroids, booked for abdominal myomectomy and received tourniquet during surgery
Exclusion criteria
Exclusion criteria: Women with previous abdominal surgeries except previous myomectomy Women suspected of genital tract malignancy Women with personal or family history of bleeding disorders Women with history of systemic disease that may increase risk of complication during surgery such as diabetes mellitus, cardiovascular disease and thyroid disease Patients on anticoagulant therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The volume of estimated intra-operative blood loss in the two groups obtained by converting the difference in weights of the mops, gauze, surgical drapes and towels after use to volume plus the volume of blood in the suction bottle at the end of surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| The volume of post-operative blood loss (blood collected in the drain from end of surgery to the time the effluent is no longer macroscopically bloody). The difference in pre-op and post-op haemoglobin (g/dl) (post-op Hb is done 48 hours after surgery via venous blood and subtracted from the pre-op Hb). The rate of nausea, vomiting, or shivering (number of patients who developed any or all in the first 24 hours of surgery). | — |
Countries
Nigeria
Contacts
Public ContactNnagbo Johnpaul
Senior Resident Doctor
Outcome results
None listed